Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer
PaperCitations, authors & open-access status
A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 53 citations, 2017 year and hybrid oa status.
53
Citations
2017
Year
hybrid
OA Status